← Back to Search

Robotic Exoskeleton

Robotic-assist gait training device for Parkinson's Disease

N/A

Waitlist Available

Led By Mark Baron, MD

Research Sponsored by Virginia Commonwealth University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 weeks

Awards & highlights

Study Summary

This trial will test a wearable device to help people with Parkinson's disease who have trouble walking.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Safety of the Portable Exoskeleton

Secondary outcome measures

Change in Balance

Change in Caregiver QOL

Change in Freezing of Gait (FOG)

+3 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: PD participantsExperimental Treatment1 Intervention

Subjects will participate in a total of 10 walking sessions, twice per week for 5 weeks, while wearing a robotic-assist gait training device. There will also be 3 additional visits for assessments at: baseline (up to 1 prior to treatment), post (1 week after last treatment), and final (4-6 weeks after last treatment).

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Virginia Commonwealth UniversityLead Sponsor

698 Previous Clinical Trials

22,884,987 Total Patients Enrolled

Mark Baron, MDPrincipal InvestigatorVirginia Commonwealth University Health System

Robert Hand, PT, DPTPrincipal InvestigatorVirginia Commonwealth University Health System

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the eligibility for this trial contingent on age, and if so, what is the upper limit?

"Based on the eligibility requirements, appropriate candidates for this clinical trial must be between 21 and 95 years of age. Additionally, 27 trials are available to applicants under 18 while 485 studies cater to elderly participants aged 65 and above."

Answered by AI

Are new participants able to join this investigation?

"According to the latest data posted on clinicaltrials.gov, this study is open for recruitment and continues to accept candidates. The trial was originally launched in January 2020 with its most recent edit occuring in March 2022."

Answered by AI

Who should join this clinical trial to receive the greatest benefit?

"The eligibility criteria for this clinical trial necessitates that interested patients suffer from Parkinson's disease and are between 21 and 95 years old. The research is currently admitting a total of 72 participants."

Answered by AI

How many participants have enrolled in this experiment thus far?

"Affirmative. According to clinicaltrials.gov, this medical research is still open for participation as of 3/7/2022 having first been posted on 1/15/2020. 72 patients are needed from a single site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Safety and Efficacy of State-of-the-Art Exoskeleton Technology to Improve Mobility in Parkinson's Disease

2020. "Safety and Efficacy of State-of-the-Art Exoskeleton Technology to Improve Mobility in Parkinson's Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04587193.